Representative image (AI-generated) NEW DELHI: The booming demand for weight-loss drugs has now caught the attention of India’s drug regulator, with a series of raids across the country revealing just how easily these prescription medicines are finding their way to consumers.In recent weeks, inspections at 49 locations—ranging from online pharmacy warehouses and wholesalers to retail chemists and wellness clinics—have uncovered gaps in how GLP-1 drugs are being sold and promoted. For many, what should be a tightly regulated treatment is fast turning into an on-demand product.Originally developed for diabetes and certain heart conditions, GLP-1 drugs have surged in popularity as weight-loss solutions, fuelled by social media buzz and rising demand for quick results. Israel Iran WarUS-Israel-Iran War News Live Updates: Amazon Web Services ‘disrupted’ following drone attack in Bahrain; Saudi, UAE mull joining Iran war’They are talking sense’: Trump says Iran ‘agreed to not have nuclear weapon”They cannot have a nuclear weapon’: US pushes 15-point plan to end Iran war, sent via PakistanTheir growing presence in the Indian market, especially with the entry of generic versions, has only made them more accessible. But that accessibility is now raising serious concerns.Officials say the Drugs Controller General of India, along with state regulators, has stepped in to curb misuse and plug loopholes in the supply chain. The focus is on stopping sales without prescriptions, checking questionable dispensing practices and cracking down on misleading promotions.What has particularly alarmed authorities is the widening network through which these drugs are being accessed—not just pharmacies, but also online platforms and slimming clinics, often without adequate medical oversight.Earlier this month, the regulator issued a clear warning to manufacturers, banning surrogate advertising and indirect promotions that could encourage off-label use or mislead consumers.Doctors caution that these are not lifestyle products. Taken without proper supervision, GLP-1 drugs can lead to serious side effects, making self-medication risky.Regulators have reiterated that the drugs are approved in India only under strict conditions and must be prescribed by specialists such as endocrinologists or internal medicine experts, and in some cases cardiologists.With demand continuing to grow, officials say enforcement will only get stricter. Licences could be cancelled, penalties imposed and legal action initiated against violators.About the AuthorAnuja JaiswalAnuja Jaiswal is a Senior Assistant Editor at The Times of India, with an impressive 18-year career in narrative journalism. She specializes in health and heritage reporting, expertly simplifying complex health information to make it engaging and understandable for readers. Her deep dives into heritage topics are well-researched, resulting in captivating narratives that resonate with her audience. Over the years, she has worked in Chandigarh, Chhattisgarh and West UP, gaining diverse on-ground experience that shapes her storytelling.Read MoreEnd of ArticleFollow Us On Social MediaVideosAfter Dhurandhar 2 Release, Former IG Reveals Atiq Ahmed’s Pak Connection, Fake Currency Racket LinksIndia Built A Naval Network But Missed The Red Sea’s Key ChokepointLPG Ships Pine Gas And Jag Vasant Safely Cross Hormuz, Crew Hails Indian NavyIran Threats Undermine 10 Million Indian Lives, Israel’s ‘Great Plans With India’: Envoy AzarVessels ‘Going Dark’ In EEZ: Navy Chief Tripathi On ‘Emerging Flash Points’ In Indo-PacificAre Trump’s Iran Announcements Driven By Market Manipulation?; Trump Calls Modi To Discuss Iran WarIAF’s Biggest Aircraft Deal Progress To Replace Aging Fleet , C-130J, C-390 And A400M In RaceUS President Trump Dials PM Modi Amid West Asia Conflict, Discusses Strait Of HormuzIndia’s Rafale Marine Deal May Move Faster Than Planned With Trainer Arrival: Reports’India Indispensable To Asia’: Donald Trump’s War Envoy Colby Signals US Shift Amid West Asia Crisis123Photostories6 luxury electric cars that are redefining the future of drivingRam Navami 2026: What is Panakam, how to make it and why is it called Lord Rama’s favourite drinkWork, money, ego: The 3 fights that destroy even the happiest relationships– And how to fix it5 foods to add to your diet to glow from withinGautam Adani’s Ahmedabad home reflects understated luxury livingKidney health: Gurugram-based doctor shares 5 daily habits that quietly damage your kidneysSadhguru’s wisdom: 7 rules of discipline for students10 house names inspired by ancient Indian cities and their meaningsHow to grow sacred marigold flowers in your home gardenInside the love lives of ‘The Brady Bunch’ cast: From on-screen family to real-life romances123Hot PicksTrain ticket refund ruleFortnite layoffsSonia GandhiGold rate todayIncome Tax CalculatorPublic holidays March 2026Bank Holidays MarchTop TrendingLuka DoncicTom BradyRCB soldRSK MP Board 8th ResultIRCTC ticket bookingFrances TiafoeHarish RanaTrump Modi callToronto airport heistBihar Board Science Topper

Representative image (AI-generated)  NEW DELHI: The booming demand for weight-loss drugs has now caught the attention of India’s drug regulator, with a series of raids across the country revealing just how easily these prescription medicines are finding their way to consumers.In recent weeks, inspections at 49 locations—ranging from online pharmacy warehouses and wholesalers to retail chemists and wellness clinics—have uncovered gaps in how GLP-1 drugs are being sold and promoted. For many, what should be a tightly regulated treatment is fast turning into an on-demand product.Originally developed for diabetes and certain heart conditions, GLP-1 drugs have surged in popularity as weight-loss solutions, fuelled by social media buzz and rising demand for quick results. Israel Iran WarUS-Israel-Iran War News Live Updates: Amazon Web Services ‘disrupted’ following drone attack in Bahrain; Saudi, UAE mull joining Iran war’They are talking sense’: Trump says Iran ‘agreed to not have nuclear weapon”They cannot have a nuclear weapon’: US pushes 15-point plan to end Iran war, sent via PakistanTheir growing presence in the Indian market, especially with the entry of generic versions, has only made them more accessible. But that accessibility is now raising serious concerns.Officials say the Drugs Controller General of India, along with state regulators, has stepped in to curb misuse and plug loopholes in the supply chain. The focus is on stopping sales without prescriptions, checking questionable dispensing practices and cracking down on misleading promotions.What has particularly alarmed authorities is the widening network through which these drugs are being accessed—not just pharmacies, but also online platforms and slimming clinics, often without adequate medical oversight.Earlier this month, the regulator issued a clear warning to manufacturers, banning surrogate advertising and indirect promotions that could encourage off-label use or mislead consumers.Doctors caution that these are not lifestyle products. Taken without proper supervision, GLP-1 drugs can lead to serious side effects, making self-medication risky.Regulators have reiterated that the drugs are approved in India only under strict conditions and must be prescribed by specialists such as endocrinologists or internal medicine experts, and in some cases cardiologists.With demand continuing to grow, officials say enforcement will only get stricter. Licences could be cancelled, penalties imposed and legal action initiated against violators.About the AuthorAnuja JaiswalAnuja Jaiswal is a Senior Assistant Editor at The Times of India, with an impressive 18-year career in narrative journalism. She specializes in health and heritage reporting, expertly simplifying complex health information to make it engaging and understandable for readers. Her deep dives into heritage topics are well-researched, resulting in captivating narratives that resonate with her audience. Over the years, she has worked in Chandigarh, Chhattisgarh and West UP, gaining diverse on-ground experience that shapes her storytelling.Read MoreEnd of ArticleFollow Us On Social MediaVideosAfter Dhurandhar 2 Release, Former IG Reveals Atiq Ahmed’s Pak Connection, Fake Currency Racket LinksIndia Built A Naval Network But Missed The Red Sea’s Key ChokepointLPG Ships Pine Gas And Jag Vasant Safely Cross Hormuz, Crew Hails Indian NavyIran Threats Undermine 10 Million Indian Lives, Israel’s ‘Great Plans With India’: Envoy AzarVessels ‘Going Dark’ In EEZ: Navy Chief Tripathi On ‘Emerging Flash Points’ In Indo-PacificAre Trump’s Iran Announcements Driven By Market Manipulation?; Trump Calls Modi To Discuss Iran WarIAF’s Biggest Aircraft Deal Progress To Replace Aging Fleet , C-130J, C-390 And A400M In RaceUS President Trump Dials PM Modi Amid West Asia Conflict, Discusses Strait Of HormuzIndia’s Rafale Marine Deal May Move Faster Than Planned With Trainer Arrival: Reports’India Indispensable To Asia’: Donald Trump’s War Envoy Colby Signals US Shift Amid West Asia Crisis123Photostories6 luxury electric cars that are redefining the future of drivingRam Navami 2026: What is Panakam, how to make it and why is it called Lord Rama’s favourite drinkWork, money, ego: The 3 fights that destroy even the happiest relationships– And how to fix it5 foods to add to your diet to glow from withinGautam Adani’s Ahmedabad home reflects understated luxury livingKidney health: Gurugram-based doctor shares 5 daily habits that quietly damage your kidneysSadhguru’s wisdom: 7 rules of discipline for students10 house names inspired by ancient Indian cities and their meaningsHow to grow sacred marigold flowers in your home gardenInside the love lives of ‘The Brady Bunch’ cast: From on-screen family to real-life romances123Hot PicksTrain ticket refund ruleFortnite layoffsSonia GandhiGold rate todayIncome Tax CalculatorPublic holidays March 2026Bank Holidays MarchTop TrendingLuka DoncicTom BradyRCB soldRSK MP Board 8th ResultIRCTC ticket bookingFrances TiafoeHarish RanaTrump Modi callToronto airport heistBihar Board Science Topper


GLP-1 gold rush under scanner: Raids across India expose easy access to weight-loss drugs
Representative image (AI-generated)

NEW DELHI: The booming demand for weight-loss drugs has now caught the attention of India’s drug regulator, with a series of raids across the country revealing just how easily these prescription medicines are finding their way to consumers.In recent weeks, inspections at 49 locations—ranging from online pharmacy warehouses and wholesalers to retail chemists and wellness clinics—have uncovered gaps in how GLP-1 drugs are being sold and promoted. For many, what should be a tightly regulated treatment is fast turning into an on-demand product.Originally developed for diabetes and certain heart conditions, GLP-1 drugs have surged in popularity as weight-loss solutions, fuelled by social media buzz and rising demand for quick results. Their growing presence in the Indian market, especially with the entry of generic versions, has only made them more accessible. But that accessibility is now raising serious concerns.Officials say the Drugs Controller General of India, along with state regulators, has stepped in to curb misuse and plug loopholes in the supply chain. The focus is on stopping sales without prescriptions, checking questionable dispensing practices and cracking down on misleading promotions.What has particularly alarmed authorities is the widening network through which these drugs are being accessed—not just pharmacies, but also online platforms and slimming clinics, often without adequate medical oversight.Earlier this month, the regulator issued a clear warning to manufacturers, banning surrogate advertising and indirect promotions that could encourage off-label use or mislead consumers.Doctors caution that these are not lifestyle products. Taken without proper supervision, GLP-1 drugs can lead to serious side effects, making self-medication risky.Regulators have reiterated that the drugs are approved in India only under strict conditions and must be prescribed by specialists such as endocrinologists or internal medicine experts, and in some cases cardiologists.With demand continuing to grow, officials say enforcement will only get stricter. Licences could be cancelled, penalties imposed and legal action initiated against violators.



Source link

Leave a Reply

Your email address will not be published. Required fields are marked *